Like other adenocarcinomas, iCCA has a high frequency of mutations in tumor protein p53 (TP53), Kirsten rat sarcoma viral oncogene homolog (KRAS), and mothers against decapentaplegic homolog 4 (SMAD4), and these may be associated with worse prognosis (97). Here, TP53 is linked to adenocarcinoma.